153 related articles for article (PubMed ID: 33321529)
1. Recurrent Preterm Birth Reduction by 17-Hydroxyprogesterone Caproate in Dichorionic/Diamniotic Twin Gestation.
Megli C; Combs CA; Venkataramanan R; Lemon L; Caritis SN
Am J Perinatol; 2022 Aug; 39(11):1183-1188. PubMed ID: 33321529
[TBL] [Abstract][Full Text] [Related]
2. 17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial.
Blackwell SC; Gyamfi-Bannerman C; Biggio JR; Chauhan SP; Hughes BL; Louis JM; Manuck TA; Miller HS; Das AF; Saade GR; Nielsen P; Baker J; Yuzko OM; Reznichenko GI; Reznichenko NY; Pekarev O; Tatarova N; Gudeman J; Birch R; Jozwiakowski MJ; Duncan M; Williams L; Krop J
Am J Perinatol; 2020 Jan; 37(2):127-136. PubMed ID: 31652479
[TBL] [Abstract][Full Text] [Related]
3. Preventing recurrent preterm birth with 125 mg of 17-alpha-hydroxyprogesterone caproate.
Fukuda T; Kyozuka H; Murata T; Yasuda S; Yamaguchi A; Fujimori K
J Obstet Gynaecol Res; 2021 Sep; 47(9):3119-3126. PubMed ID: 34219326
[TBL] [Abstract][Full Text] [Related]
4. Intramuscular progesterone in women with twins and a prior singleton spontaneous preterm birth.
Ward A; Greenberg V; Valcarcel B; Boelig RC; Al-Kouatly HB; Berghella V
Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100124. PubMed ID: 33345870
[TBL] [Abstract][Full Text] [Related]
5. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.
Shambhavi S; Bagga R; Bansal P; Kalra J; Kumar P
J Obstet Gynaecol; 2018 Aug; 38(6):800-806. PubMed ID: 29557230
[TBL] [Abstract][Full Text] [Related]
6. Vaginal progesterone vs intramuscular 17α-hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth in singleton gestations: systematic review and meta-analysis of randomized controlled trials.
Saccone G; Khalifeh A; Elimian A; Bahrami E; Chaman-Ara K; Bahrami MA; Berghella V
Ultrasound Obstet Gynecol; 2017 Mar; 49(3):315-321. PubMed ID: 27546354
[TBL] [Abstract][Full Text] [Related]
7. A Possible Mechanism of Action of 17α-Hydroxyprogesterone Caproate: Enhanced IL-10 Production.
Megli CJ; Hauspurg A; Venkataramanan R; Caritis SN
Am J Perinatol; 2023 Oct; 40(14):1585-1589. PubMed ID: 34784615
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant 17-hydroxyprogesterone caproate in women with history-indicated cerclage: A systematic review and meta-analysis.
Eke AC; Sheffield J; Graham EM
Acta Obstet Gynecol Scand; 2019 Feb; 98(2):139-153. PubMed ID: 30339274
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant 17-hydroxyprogesterone caproate in women withultrasound-indicated cerclage: a systematic review and meta-analysis.
Lichter KE; Sheffield J; Graham EM; Eke AC
J Matern Fetal Neonatal Med; 2020 Sep; 33(18):3177-3184. PubMed ID: 30626240
[No Abstract] [Full Text] [Related]
10. Vaginal progesterone vs intramuscular 17-hydroxyprogesterone caproate for prevention of recurrent preterm birth: a randomized controlled trial.
Boelig RC; Schoen CN; Frey H; Gimovsky AC; Springel E; Backley S; Berghella V
Am J Obstet Gynecol; 2022 May; 226(5):722.e1-722.e12. PubMed ID: 35189093
[TBL] [Abstract][Full Text] [Related]
11. Impact of Obesity on the Rate of Recurrent Spontaneous Preterm Birth in Women Treated with 17-alpha Hydroxyprogesterone Caproate.
Hauspurg A; Lemon LS; Serra AE; Sharma S; Venkataramanan R; Caritis SN
Am J Perinatol; 2018 Jul; 35(9):809-814. PubMed ID: 29294501
[TBL] [Abstract][Full Text] [Related]
12. Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation.
Caritis SN; Simhan HN; Zhao Y; Rouse DJ; Peaceman AM; Sciscione A; Spong CY; Varner MW; Malone FD; Iams JD; Mercer BM; Thorp JM; Sorokin Y; Carpenter M; Lo J; Ramin SM; Harper M;
Am J Obstet Gynecol; 2012 Nov; 207(5):396.e1-8. PubMed ID: 22959763
[TBL] [Abstract][Full Text] [Related]
13. Role of progesterone, cerclage and pessary in preventing preterm birth in twin pregnancies: A systematic review and network meta-analysis.
D'Antonio F; Berghella V; Di Mascio D; Saccone G; Sileo F; Flacco ME; Odibo AO; Liberati M; Manzoli L; Khalil A
Eur J Obstet Gynecol Reprod Biol; 2021 Jun; 261():166-177. PubMed ID: 33946019
[TBL] [Abstract][Full Text] [Related]
14. Does 17-α-hydroxyprogesterone caproate affect fetal biometry and birth weight in twin pregnancy?
Mulder EJ; Versteegh EM; Bloemenkamp KW; Lim AC; Mol BW; Bekedam DJ; Kwee A; Bruinse HW; Christiaens GC
Ultrasound Obstet Gynecol; 2013 Sep; 42(3):329-34. PubMed ID: 23592400
[TBL] [Abstract][Full Text] [Related]
15. A Double-Blind, Randomized, Placebo-Controlled Trial of 17 Alpha-hydroxyprogesterone Caproate in the Management of Preterm Premature Rupture of Membranes.
Langen ES; Sit A; Sherwin K; Lyell DJ; Blumenfeld YJ; El-Sayed YY
Am J Perinatol; 2018 Jul; 35(8):779-784. PubMed ID: 29298456
[TBL] [Abstract][Full Text] [Related]
16. Gestational age at initiation of 17-alpha hydroxyprogesterone caproate and recurrent preterm birth.
Ning A; Vladutiu CJ; Dotters-Katz SK; Goodnight WH; Manuck TA
Am J Obstet Gynecol; 2017 Sep; 217(3):371.e1-371.e7. PubMed ID: 28526452
[TBL] [Abstract][Full Text] [Related]
17. Utilization, adherence, and outcomes of 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention.
Zhang S; Rascati KL
Curr Med Res Opin; 2021 Sep; 37(9):1667-1675. PubMed ID: 34030550
[TBL] [Abstract][Full Text] [Related]
18. Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate.
Manuck TA; Lai Y; Meis PJ; Dombrowski MP; Sibai B; Spong CY; Rouse DJ; Durnwald CP; Caritis SN; Wapner RJ; Mercer BM; Ramin SM
Am J Obstet Gynecol; 2011 Aug; 205(2):135.e1-9. PubMed ID: 21600550
[TBL] [Abstract][Full Text] [Related]
19. A chronicle of the 17-alpha hydroxyprogesterone caproate story to prevent recurrent preterm birth.
Nelson DB; McIntire DD; Leveno KJ
Am J Obstet Gynecol; 2021 Feb; 224(2):175-186. PubMed ID: 33035472
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation.
Caritis SN; Sharma S; Venkataramanan R; Rouse DJ; Peaceman AM; Sciscione A; Spong CY; Varner MW; Malone FD; Iams JD; Mercer BM; Thorp JM; Sorokin Y; Carpenter M; Lo J; Ramin S; Harper M;
Am J Obstet Gynecol; 2011 Jul; 205(1):40.e1-8. PubMed ID: 21620357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]